{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:22:28Z","timestamp":1790688148966,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.4158\/ep.14.9.1126","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T22:30:01Z","timestamp":1365201001000},"page":"1126-1132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevalence of Reproductive Abnormalities Among Women with Familial Partial Lipodystrophy"],"prefix":"10.1016","volume":"14","author":[{"given":"Tisha R.","family":"Joy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP.14.9.1126_bb0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1126_bb0010","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1126_bb0015","series-title":"Polycystic Ovary Syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.4158\/EP.14.9.1126_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.4158\/EP.14.9.1126_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.4158\/EP.14.9.1126_bb0030","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome; an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1126_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1126_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.4158\/EP.14.9.1126_bb0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.9.1126_bb0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.4158\/EP.14.9.1126_bb0055","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1161\/01.ATV.0000136392.59656.8b","article-title":"Laminopathies and atherosclerosis","volume":"24","author":"Al-Shali","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.4158\/EP.14.9.1126_bb0060","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","article-title":"Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state","volume":"23","author":"K\u00f6bberling","year":"1986","journal-title":"J Med Genet"},{"key":"10.4158\/EP.14.9.1126_bb0065","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4158\/EP.14.9.1126_bb0070","first-page":"145","article-title":"Congenital lipodystrophy and polycystic ovarian disease","volume":"26","author":"Penney","year":"1981","journal-title":"J Reprod Med"},{"key":"10.4158\/EP.14.9.1126_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.4158\/EP.14.9.1126_bb0080","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"10.4158\/EP.14.9.1126_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"10.4158\/EP.14.9.1126_bb0090","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C [published correction appears in Am J Hum Genet. 2000;67:775]","volume":"66","author":"Speckman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.4158\/EP.14.9.1126_bb0095","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP.14.9.1126_bb0100","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1101\/gr.10.5.652","article-title":"Association between nuclear lamin A\/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes","volume":"10","author":"Hegele","year":"2000","journal-title":"Genome Res"},{"key":"10.4158\/EP.14.9.1126_bb0105","author":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS)"},{"key":"10.4158\/EP.14.9.1126_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-3476(79)80087-6","article-title":"Congenital lipodystrophy. II. Association with polycystic ovarian disease","volume":"95","author":"Huseman","year":"1979","journal-title":"J Pediatr"},{"key":"10.4158\/EP.14.9.1126_bb0115","first-page":"2223","article-title":"Defrance- Faivre F, et al","volume":"93","author":"Vantyghem","year":"2008","journal-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J Clin Endocrinol Metab"},{"issue":"34","key":"10.4158\/EP.14.9.1126_bb0120","first-page":"e1","article-title":"Inpatient hysterectomy surveillance in the United States, 2000-2004","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP.14.9.1126_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humrep\/dem356","article-title":"Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome","volume":"23","author":"Cascella","year":"2008","journal-title":"Hum Reprod"},{"key":"10.4158\/EP.14.9.1126_bb0130","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1194\/jlr.R700004-JLR200","article-title":"Thematic review series: adipocyte biology; lipodystrophies; windows on adipose biology and metabolism","volume":"48","author":"Hegele","year":"2007","journal-title":"J Lipid Res"},{"key":"10.4158\/EP.14.9.1126_bb0135","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI14120","article-title":"Endogenous glucose production is inhibited by the adipose- derived protein Acrp30","volume":"108","author":"Combs","year":"2001","journal-title":"J Clin Invest"},{"key":"10.4158\/EP.14.9.1126_bb0140","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.222657499","article-title":"Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation","volume":"99","author":"Tomas","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4158\/EP.14.9.1126_bb0145","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.4158\/EP.14.9.1126_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1262-3636(07)70084-8","article-title":"Adipose tissue and adipokines: for better or worse","volume":"30","author":"Guerre-Millo","year":"2004","journal-title":"Diabetes Metab"},{"key":"10.4158\/EP.14.9.1126_bb0155","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00125-005-0038-x","article-title":"Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A\/C","volume":"48","author":"Wong","year":"2005","journal-title":"Diabetologia"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20416428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20416428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/T220TG0506265782.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:48:45Z","timestamp":1761515325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20416428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1530891X20416428"],"URL":"https:\/\/doi.org\/10.4158\/ep.14.9.1126","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Reproductive Abnormalities Among Women with Familial Partial Lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.14.9.1126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}